DJIA 17,440.59 -127.94 -0.73%
NASDAQ 5,039.78 -48.85 -0.96%
S&P 500 2,067.64 -12.01 -0.58%
market minute promo

GlaxoSmithKline (NYSE: GSK)

41.60 0.21 (0.51%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GSK $41.60 0.51%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $41.47
Previous Close $41.39
Daily Range $41.28 - $41.64
52-Week Range $41.19 - $49.24
Market Cap $100.5B
P/E Ratio 14.22
Dividend (Yield) $2.34 (6.1%)
Ex-Dividend Date
Dividend Pay Date
05/13/15
07/09/15
Volume 2,644,492
Average Daily Volume 3,871,692
Current FY EPS $2.44

Sector

Healthcare

Industry

Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary

3 Questions GlaxoSmithKline Investors Want Answered on July 29

Pharmaceutical giant GlaxoSmithKline is slated to report its second-quarter results on July 29. Here are three questions investors want answered in Glaxo's report.

Will Headwinds Weigh on Glaxo's (GSK) Earnings in Q2? - Analyst Blog

HIV/HPV Guru Comes On Board To Battle Cancer, Driving CEL-SCI's Market Opportunity

The Importance Of Newly-Released Data For Gilead's HIV Drug Patent Cliff

Perrigo (PRGO) to Buy Yokebe Brand; Boost EU Presence - Analyst Blog

3 Buy-Rated Dividend Stocks: TLLP, GSK, RLJ

Novartis (NVS) Beats on Earnings in Q2, 2015 View Retained - Analyst Blog

Will Agenus (AGEN) Disappoint Investors this Earnings? - Analyst Blog

Pre-Market Most Active for Jul 20, 2015 : EXEL, PYPL, AAPL, NOK, VOD, GSK, ABX, VSLR, FB, QQQ, TS,

Pre-Market Most Active for Jul 20, 2015 : EXEL, PYPL, AAPL, NOK, VOD, GSK, ABX, VSLR, FB, QQQ, TS, BAC

Why Shares in Axovant Sciences Are Soaring 20% Higher Today

Axovant Sciences shares are jumping ahead of a key industry conference and investor webcast next week.

See More GSK News...

GSK's Top Competitors

GSK $41.60 (0.51%)
Current stock: GSK
JNJ $98.28 (-0.88%)
Current stock: JNJ
NVS $101.54 (-0.26%)
Current stock: NVS
RHHBY $35.60 (-1.00%)
Current stock: RHHBY